Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 50INDUSTRY 18NIH 4NETWORK 3UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 8Breast Neoplasms 5Triple Negative Breast Neoplasms 3Stomach Neoplasms 1Recurrence 1Nasopharyngeal Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Cisplatin 2nedaplatin 1durvalumab 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1Irinotecan 1Drug Therapy 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Squamous Cell Carcinoma × Paclitaxel × Clear all
NCT05522894 2022-08-31

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

ChineseAMS

Phase 2 Unknown
80 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡